ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMA....MD..........*XBDM Ver 0.1.63 (23 May 2017) - 1100000/03271371A120180124EP16759215.32016030220170913enenen155024220150302SE155025620150304SE155025720150304SE155025820150304SE155025920150304SE155026020150304SE155026120150304SE155026520150304SE2018012420180420180124201804C07H 19/10 20060101AFI20160914BHEP A61K 31/7072 20060101ALI20160914BHEP A61P 31/14 20060101ALI20160914BHEP deNUKLEOTIDDERIVATE, DIE HCV-INHIBITOREN SIND, ZUR VERWENDUNG IN DER BEHANDLUNG VON HEPATITIS CenNUCLEOTIDE DERIVATIVES WHICH ARE HCV INHIBITORS FOR USE IN THE TREATMENT OF HEPATITIS CfrDÉRIVÉS NUCLÉOTIDIQUES QUI SONT DES INHIBITEURS DU VHC POUR UNE UTILISATION DANS LE TRAITEMENT DE L'HÉPATITE CMEDIVIR AB101691956M347 EPPO Box 1086141 22 HuddingeSEKALAYANOV, Gennadiyc/o Medivir AB Box 1086141 22 HuddingeSEPINHO, Pedroc/o Medivir AB Box 1086141 22 HuddingeSETARGETT-ADAMS, Paulc/o Medivir AB141 22 HuddingeSETORSSELL, Staffanc/o Medivir AB Box 1086141 22 HuddingeSEALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBAMEMAMDSE201605016620160302enWO201614061520160909201636